2021-2031 年北美颅脑植入物市场报告(范围、细分、动态和竞争分析)
市场调查报告书
商品编码
1843352

2021-2031 年北美颅脑植入物市场报告(范围、细分、动态和竞争分析)

North America Cranial Implants Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: | 出版商: The Insight Partners | 英文 183 Pages | 订单完成后即时交付

价格

北美颅骨植入物市场预计将大幅成长,到 2031 年将达到约 11.6,677 亿美元,高于 2023 年的 6.7428 亿美元,反映出 2023 年至 2031 年的年复合成长率(CAGR) 为 7.1%。

执行摘要和市场分析

北美颅骨植入物市场主要分为三个区域:美国、加拿大和墨西哥。推动该市场成长的因素包括创伤性脑损伤 (TBI) 的高发病率、人口老化以及医疗技术的进步。事故、运动伤害和神经系统疾病的发生率不断上升,推动了颅骨植入物的需求。聚醚醚酮 (PEEK) 和钛等生物相容性材料的创新,以及 3D 列印技术在个人化解决方案中的应用,正在提升手术效果。该领域的公司也致力于创新,使颅骨植入手术更有效、更方便。

市场区隔分析

北美颅骨植入物市场可以透过类型、材料和应用等各个部分进行分析。

  • 依类型:市场分为顶骨植入物、额骨植入物、枕骨植入物、颞骨植入物和蝶骨植入物。 2023年,顶骨植入物占据了最大的市场。
  • 依材料分类:依材料细分包括聚甲基丙烯酸甲酯、聚醚醚酮、钛等。聚醚醚酮是2023年市占率领先的材料。
  • 按最终用户划分:最终用户细分包括医院、创伤中心和其他,其中医院在 2023 年占据最大份额。

市场展望

创伤性脑损伤是一个重大的公共卫生问题,它因外部机械力而扰乱正常的大脑功能。 TBI 的常见原因包括跌倒、车祸和运动伤害,主要影响年轻人和老年人。 TBI 的严重程度从轻微脑震盪到导致长期认知、身体和情感障碍的严重损伤不等。 《柳叶刀》神经学委员会 2022 年的报告强调,TBI 是造成伤害相关死亡和残疾的主要原因之一,全球有 5,500 万人受到影响,每年造成超过 4,000 亿美元的损失。在加拿大,滑铁卢-惠灵顿脑损伤协会报告称,每年每 10 万人中就有 500 人发生 TBI,每年有超过 6000 名患者因 TBI 永久残疾。随着 TBI 发病率的上升,对有效治疗方案(尤其是颅脑植入物)的需求不断增长。这些植入物对于治疗严重的头部损伤、保护大脑免受进一步损伤以及恢復颅骨的保护功能至关重要。随着创伤性脑损伤(TBI)病例的持续增加,预计未来几年颅骨植入物的需求将大幅增加。

国家洞察

北美颅骨植入物市场主要由美国、加拿大和墨西哥组成,其中美国在2023年占据最大市场份额。该地区的成长归因于创伤性脑损伤(TBI)的高发病率、人口老化以及先进医疗技术的普及。事故、运动伤害和神经系统疾病的增加进一步刺激了颅骨植入物的需求。生物相容性材料和3D列印技术的创新正在改善手术效果,使手术更加有效且更易于操作。

公司简介

北美颅骨植入物市场的主要参与者包括史赛克公司 (Stryker Corp)、捷迈邦美控股公司 (Zimmer Biomet Holdings Inc)、Integra LifeSciences Holdings Corp、OsteoMed SA、Anatomics Pty Ltd、Matrix Surgical Holdings LLC、Calavera Surgical、美敦力公司 (Medtronic Plcevx)、Xxer KG、B Braun SE、UAB Ortho Baltic、3D Systems Corp、GPC Medical Ltd、Bioplate Inc、EUROS SAS、Biocomposites Ltd、Medprin Biotech GmbH、Kelyniam Global Inc、MedCAD、KLS Martin Group 和 Longeviti Neuro Solutions LLC 等。这些公司正在采用各种策略,包括扩张、产品创新和併购,以增强其产品供应并提高市场份额。

目录

第一章:简介

第二章:执行摘要

  • 关键见解

第三章:研究方法

  • 二次研究
  • 初步研究
    • 假设表述:
    • 宏观经济因素分析:
    • 显影基数:
    • 数据三角测量:
    • 国家级资料:

第四章:北美颅骨植入物市场概况

  • 概述
  • PEST分析

北美颅骨植入物市场—关键市场动态

  • 北美颅骨植入物市场—关键市场动态
  • 市场驱动因素
    • 创伤性脑损伤盛行率上升
    • 老年人口激增
  • 市场限制
    • 植入物失败的风险
  • 市场机会
    • 融入原创多层技术的3D列印技术进步
  • 未来趋势
    • 客製化植入物
  • 驱动因素和限制因素的影响:

第五章:北美颅骨植入物市场 - 分析

  • 2021-2031年北美颅骨植入物市场收入
  • 北美颅骨植入物市场预测分析

第六章:北美颅骨植入物市场分析—依类型

  • 顶叶
  • 额叶
  • 枕骨
  • 蝶骨

第七章:北美颅骨植入物市场分析-依材料

  • 聚甲基丙烯酸甲酯
  • 聚醚醚酮
  • 其他的

第 8 章:北美颅骨植入物市场分析 - 依最终用户

  • 医院
  • 创伤中心
  • 其他的

第九章:北美颅骨植入物市场—国家分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第十章:产业格局

  • 概述
  • 併购
  • 产品发布
  • 扩张和其他策略发展

第 11 章:公司简介

  • Stryker Corp
  • Zimmer Biomet Holdings Inc
  • Integra LifeSciences Holdings Corp
  • OsteoMed SA
  • Anatomics Pty Ltd
  • Matrix Surgical Holdings LLC
  • Calavera Surgical
  • Medtronic Plc
  • Xilloc Medical BV
  • Johnson & Johnson
  • evonos GmbH & Co. KG
  • B Braun SE
  • UAB Ortho Baltic
  • 3D Systems Corp
  • GPC Medical Ltd
  • Bioplate Inc
  • EUROS SAS
  • Biocomposites Ltd
  • Medprin Biotech GmbH
  • Kelyniam Global Inc
  • MedCAD
  • KLS Martin Group
  • Longeviti Neuro Solutions LLC

第 12 章:附录

Product Code: BMIRE00031980

The North America cranial implants market is projected to grow significantly, reaching approximately US$ 1,166.77 million by 2031, up from US$ 674.28 million in 2023, reflecting a compound annual growth rate (CAGR) of 7.1% from 2023 to 2031.

Executive Summary and Market Analysis

The cranial implants market in North America is divided into three main regions: the United States, Canada, and Mexico. Several factors are propelling the growth of this market, including a high incidence of traumatic brain injuries (TBI), an aging demographic, and advancements in medical technology. The increasing rates of accidents, sports-related injuries, and neurological disorders are driving the demand for cranial implants. Innovations in biocompatible materials, such as polyether ether ketone (PEEK) and titanium, along with the use of 3D printing for personalized solutions, are enhancing surgical outcomes. Companies in the sector are also focusing on innovation to make cranial implant procedures more effective and accessible.

Market Segmentation Analysis

The North America cranial implants market can be analyzed through various segments, including type, material, and application.

  • By Type: The market is categorized into parietal, frontal, occipital, temporal, and sphenoid implants. In 2023, parietal implants accounted for the largest market share.
  • By Material: The segmentation by material includes polymethyl methacrylate, polyether ether ketone, titanium, and others. Polyether ether ketone was the leading material in market share in 2023.
  • By End User: The end-user segmentation includes hospitals, trauma centers, and others, with hospitals holding the largest share in 2023.

Market Outlook

Traumatic brain injuries are a major public health issue, disrupting normal brain function due to external mechanical forces. Common causes of TBIs include falls, motor vehicle accidents, and sports injuries, predominantly affecting younger and older adults. TBIs can range from mild concussions to severe injuries that lead to long-term cognitive, physical, and emotional disabilities. A report from The Lancet Neurology Commissions in 2022 highlighted that TBIs are among the leading causes of injury-related death and disability, impacting 55 million individuals globally and costing over US$ 400 billion annually. In Canada, the Brain Injury Association of Waterloo-Wellington reports that TBIs occur in 500 out of 100,000 people each year, with over 6,000 patients becoming permanently disabled due to TBIs annually. The rising demand for effective treatment options, particularly cranial implants, is driven by the increasing incidence of TBIs. These implants are essential for treating severe head injuries, protecting the brain from further damage, and restoring the skull's protective function. As TBI cases continue to rise, the demand for cranial implants is expected to increase significantly in the coming years.

Country Insights

The North America cranial implants market is primarily composed of the US, Canada, and Mexico, with the US holding the largest market share in 2023. The growth in this region is attributed to the high prevalence of TBIs, an aging population, and the availability of advanced medical technologies. The increasing number of accidents, sports injuries, and neurological conditions further fuels the demand for cranial implants. Innovations in biocompatible materials and 3D printing technology are improving surgical outcomes and making procedures more effective and accessible.

Company Profiles

Key players in the North America cranial implants market include Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, Calavera Surgical, Medtronic Plc, Xilloc Medical BV, Johnson & Johnson, evonos GmbH & Co. KG, B Braun SE, UAB Ortho Baltic, 3D Systems Corp, GPC Medical Ltd, Bioplate Inc, EUROS SAS, Biocomposites Ltd, Medprin Biotech GmbH, Kelyniam Global Inc, MedCAD, KLS Martin Group, and Longeviti Neuro Solutions LLC, among others. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their product offerings and increase market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Cranial Implants Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

North America Cranial Implants Market - Key Market Dynamics

  • 4.3 North America Cranial Implants Market - Key Market Dynamics
  • 4.4 Market Drivers
    • 4.4.1 Increase in the Prevalence of Traumatic Brain Injuries
    • 4.4.2 Surge in Elderly Populations
  • 4.5 Market Restraints
    • 4.5.1 Risk of Implant Failure
  • 4.6 Market Opportunities
    • 4.6.1 Advancements in 3D Printing with Incorporation of Original Multilayer Technology
  • 4.7 Future Trends
    • 4.7.1 Customized Implants
  • 4.8 Impact of Drivers and Restraints:

5. North America Cranial Implants Market - Analysis

  • 5.1 North America Cranial Implants Market Revenue (US$ Million), 2021-2031
  • 5.2 North America Cranial Implants Market Forecast Analysis

6. North America Cranial Implants Market Analysis - by Type

  • 6.1 Parietal
    • 6.1.1 Overview
    • 6.1.2 Parietal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Frontal
    • 6.2.1 Overview
    • 6.2.2 Frontal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Occipital
    • 6.3.1 Overview
    • 6.3.2 Occipital: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Temporal
    • 6.4.1 Overview
    • 6.4.2 Temporal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Sphenoid
    • 6.5.1 Overview
    • 6.5.2 Sphenoid: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. North America Cranial Implants Market Analysis - by Material

  • 7.1 Polymethyl Methacrylate
    • 7.1.1 Overview
    • 7.1.2 Polymethyl Methacrylate: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Polyether Ether Ketone
    • 7.2.1 Overview
    • 7.2.2 Polyether Ether Ketone: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Titanium
    • 7.3.1 Overview
    • 7.3.2 Titanium: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Cranial Implants Market Analysis - by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Hospitals: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Trauma Centers
    • 8.2.1 Overview
    • 8.2.2 Trauma Centers: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Cranial Implants Market - Country Analysis

  • 9.1 North America
    • 9.1.1 North America Cranial Implants Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 North America Cranial Implants Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.2 United States: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.2.1 United States: North America Cranial Implants Market Share - by Type
        • 9.1.1.2.2 United States: North America Cranial Implants Market Share - by Material
        • 9.1.1.2.3 United States: North America Cranial Implants Market Share - by End User
      • 9.1.1.3 Canada: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.3.1 Canada: North America Cranial Implants Market Share - by Type
        • 9.1.1.3.2 Canada: North America Cranial Implants Market Share - by Material
        • 9.1.1.3.3 Canada: North America Cranial Implants Market Share - by End User
      • 9.1.1.4 Mexico: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.4.1 Mexico: North America Cranial Implants Market Share - by Type
        • 9.1.1.4.2 Mexico: North America Cranial Implants Market Share - by Material
        • 9.1.1.4.3 Mexico: North America Cranial Implants Market Share - by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Mergers and Acquisitions
  • 10.3 Product Launch
  • 10.4 Expansions and Other Strategic Developments

11. Company Profiles

  • 11.1 Stryker Corp
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Zimmer Biomet Holdings Inc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Integra LifeSciences Holdings Corp
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 OsteoMed SA
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Anatomics Pty Ltd
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Matrix Surgical Holdings LLC
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Calavera Surgical
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Medtronic Plc
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Xilloc Medical BV
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Johnson & Johnson
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 evonos GmbH & Co. KG
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 B Braun SE
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Products and Services
    • 11.12.4 Financial Overview
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments
  • 11.13 UAB Ortho Baltic
    • 11.13.1 Key Facts
    • 11.13.2 Business Description
    • 11.13.3 Products and Services
    • 11.13.4 Financial Overview
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Developments
  • 11.14 3D Systems Corp
    • 11.14.1 Key Facts
    • 11.14.2 Business Description
    • 11.14.3 Products and Services
    • 11.14.4 Financial Overview
    • 11.14.5 SWOT Analysis
    • 11.14.6 Key Developments
  • 11.15 GPC Medical Ltd
    • 11.15.1 Key Facts
    • 11.15.2 Business Description
    • 11.15.3 Products and Services
    • 11.15.4 Financial Overview
    • 11.15.5 SWOT Analysis
    • 11.15.6 Key Developments
  • 11.16 Bioplate Inc
    • 11.16.1 Key Facts
    • 11.16.2 Business Description
    • 11.16.3 Products and Services
    • 11.16.4 Financial Overview
    • 11.16.5 SWOT Analysis
    • 11.16.6 Key Developments
  • 11.17 EUROS SAS
    • 11.17.1 Key Facts
    • 11.17.2 Business Description
    • 11.17.3 Products and Services
    • 11.17.4 Financial Overview
    • 11.17.5 SWOT Analysis
    • 11.17.6 Key Developments
  • 11.18 Biocomposites Ltd
    • 11.18.1 Key Facts
    • 11.18.2 Business Description
    • 11.18.3 Products and Services
    • 11.18.4 Financial Overview
    • 11.18.5 SWOT Analysis
    • 11.18.6 Key Developments
  • 11.19 Medprin Biotech GmbH
    • 11.19.1 Key Facts
    • 11.19.2 Business Description
    • 11.19.3 Products and Services
    • 11.19.4 Financial Overview
    • 11.19.5 SWOT Analysis
    • 11.19.6 Key Developments
  • 11.20 Kelyniam Global Inc
    • 11.20.1 Key Facts
    • 11.20.2 Business Description
    • 11.20.3 Products and Services
    • 11.20.4 Financial Overview
    • 11.20.5 SWOT Analysis
    • 11.20.6 Key Developments
  • 11.21 MedCAD
    • 11.21.1 Key Facts
    • 11.21.2 Business Description
    • 11.21.3 Products and Services
    • 11.21.4 Financial Overview
    • 11.21.5 SWOT Analysis
    • 11.21.6 Key Developments
  • 11.22 KLS Martin Group
    • 11.22.1 Key Facts
    • 11.22.2 Business Description
    • 11.22.3 Products and Services
    • 11.22.4 Financial Overview
    • 11.22.5 SWOT Analysis
    • 11.22.6 Key Developments
  • 11.23 Longeviti Neuro Solutions LLC
    • 11.23.1 Key Facts
    • 11.23.2 Business Description
    • 11.23.3 Products and Services
    • 11.23.4 Financial Overview
    • 11.23.5 SWOT Analysis
    • 11.23.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 List of Abbreviations

List Of Tables

  • Table 1. North America Cranial Implants Market Segmentation
  • Table 2. North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Material
  • Table 5. North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 6. North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. United States: North America Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 8. United States: North America Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 9. United States: North America Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 10. Canada: North America Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 11. Canada: North America Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 12. Canada: North America Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 13. Mexico: North America Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 14. Mexico: North America Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Material
  • Table 15. Mexico: North America Cranial Implants Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 16. List of Abbreviations

List Of Figures

  • Figure 1. North America Cranial Implants Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Cranial Implants Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Cranial Implants Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Parietal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Frontal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Occipital: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Temporal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Sphenoid: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. North America Cranial Implants Market Share (%) - by Material (2023 and 2031)
  • Figure 12. Polymethyl Methacrylate: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Polyether Ether Ketone: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Titanium: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Others: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. North America Cranial Implants Market Share (%) - by End User (2023 and 2031)
  • Figure 17. Hospitals: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Trauma Centers: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Others: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. North America Cranial Implants Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 21. United States: North America Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Canada: North America Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. Mexico: North America Cranial Implants Market - Revenue and Forecast, 2021- 2031 (US$ Million)